CMS Delays CAR-T Coverage Policy Without Explanation

By John Wilkerson / May 17, 2019 at 4:10 PM
CMS delayed, without explanation, the national Medicare coverage policy for new expensive hospital-administered cancer drugs that was due to be published Friday (May 17). “CMS will not be issuing a final National Coverage Determination on CAR T-cell therapy for cancer today, but a decision is forthcoming.” states an agency press release on the final national coverage determination for chimeric antigen receptor (CAR) T-cell therapy. That single sentence is all CMS released, and an agency spokesperson declined to say why the...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.